US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 9, 2022 (4 years ago)

Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.

What was recalled

Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834

Recalling firm
Mayne Pharma Inc
NDC code
51862-455-01
Origin
NC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1152-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Clonidine recalls

See all